Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | daunorubicin | 30323 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | daunorubicin | 30323 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | daunorubicin | 30323 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | daunorubicin | 30323 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | daunorubicin | 30323 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | daunorubicin | 30323 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | daunorubicin | 30323 | drug-path |
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | daunorubicin | 30323 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | daunorubicin | 30323 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | daunorubicin | 30323 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | daunorubicin | 30323 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | daunorubicin | 30323 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | daunorubicin | 30323 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | daunorubicin | 30323 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | daunorubicin | 30323 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | daunorubicin | 30323 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | daunorubicin | 30323 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | daunorubicin | 30323 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | methyldopate | 17277 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | methyldopate | 17277 | drug-path |